Medicines authorised in Romania

Opzelura

Opzelura is a medicine containing Ruxolitinib, listed in the Romanian national register of medicines for human use with 1 presentation.

General information from the official register, not medical advice. Anpheros does not diagnose and does not recommend medicines. Read the package leaflet and ask your doctor or pharmacist before taking any medicine.

At a glance

Active substance
RUXOLITINIBUM · all medicines with Ruxolitinib
ATC code
D11AH Dermatologicals
Therapeutic action
ALTE PREPARATE DE UZ DERMATOLOGIC ALTE PREPARATE DE UZ DERMATOLOGIC
Prescription
Prescription required (register code PR)
Marketing authorisation holder
INCYTE BIOSCIENCES DISTRIBUTION B.V. - OLANDA
Manufacturer
INCYTE BIOSCIENCES DISTRIBUTION B.V. - OLANDA
Pharmaceutical form
CREMA

Presentations and codes

CIM is the code of each pack in the Romanian register; the Anpheros app saves it when it recognises the box.

CIM codeFormStrengthPackPrescriptionAuthorisationShelf life
W71647001CREMA15mg/gCutie cu 1 tub laminat x 100 g cremaPR1726/2023/0221 luni;dupa prima deschidere: 6 luni

What it is used for

The official indications for Ruxolitinib, quoted from the European Medicines Agency and the US FDA, are on Ruxolitinib in Anpheros Search.

The package leaflet and the summary of product characteristics are published by ANMDMR: search for “Opzelura” in the national register.

Other medicines with Ruxolitinib

Scan the box in Anpheros

In the Anpheros Daily app, photograph the medicine box: the app reads the name and strength, matches them against this register and adds the medicine to your list, with its code. From your list you can come back to this page.

Get the app

Source: ANMDMR — National Agency for Medicines and Medical Devices of Romania, Nomenclatorul medicamentelor de uz uman (register updated 29 October 2026). Shown as published, in Romanian where the register is in Romanian.